Takeda appoints Rhonda Pacheco President of US Business Unit
Rhonda Pacheco to succeed Julie Kim, who was appointed to be Takeda’s next CEO
Rhonda Pacheco to succeed Julie Kim, who was appointed to be Takeda’s next CEO
He has been associated with the Zydus Group since 2009
Anthony brings more than 25 years of pharmaceutical development and CRO experience to his expanded role
Baruah will lead strategy, growth, and transformation across the HLS vertical, focusing on expanding digital health capabilities and accelerating AI adoption
Novo Nordisk will merge its Research & Early Development and Development functions into a single R&D unit
Mantri will replace V. S. Mani, Executive Director & Global Chief Financial Officer of the company as he has conveyed his decision to opt for early retirement
With over 28 years of experience in the pharmaceutical industry, he is a seasoned Techno? Commercial professional and accomplished top management leader
He has 29+ years’ comprehensive experience in world-class Formulations and API (for US and EU requirements) mainly related to injectables
The President said that there is a need to spread more and more awareness regarding the causes, diagnosis and treatment of cancer
Subscribe To Our Newsletter & Stay Updated